Liminal BioSciences Inc. LMNL

Healthcare Biotechnology

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.

NDAQ:LMNL - Post by User

Liminal BioSciences Inc. > We know what u're trying to do with your 5 words messages...

<< Previous

Bullboard Posts

Next >>

Comment by PLITheOneon May 18, 2020 11:31pm

87 Views

Post# 31044246

RE:We know what u're trying to do with your 5 words messages...

You must think everyone is just as clueless as yourself. Your credibility here is irrelevant as it should be. Everything you post here is incorrect and an attempt to avoid the obvious while hopefully influencing others. What are your true intentions here, and why is it so necessary to attempt to discount posters who have acquired a long history and knowledge of this company?
Are you Galbraith’s buddy or family?

Look below meathead at your accusations for a great example of your credibility. You should have a roll of toilet paper permanently installed under your mouth with all the chit that must come out.

Never said it was imminently going to $1 as you claim.
The only loser her is yourself proven many times by many people. Keep buying and remain silent will clean up this board.
Posted all weekend? Should be easy enough for you to do, no? Didn't post once on the weekend Bevious, Saturday nor Sunday as you claim. Just because you had signed in as Newcamo doesn’t mean it wasn’t you spreading the daily dosage of craap. Did you forget that you signed in as Newcamo?
Go crawl back into your hole. How is it that you are constantly wrong, for the year that you have been here, and assume that You, lol, have any credibility?
You're a joke man.

I do apologize to those who have chosen to ignore this clown but see these posts quoting him or setting him straight. Just can’t stand by every day and listen to all this krap without weighing in.

realstocky wrote: You also spammed all week-end, u just forgot today was a holiday:) Geniuses! Plitheone, u also said this was going to 1$... must be IMMINENTLY, right? Too bad u losers ruin this board, lmnl if they deliver only on the riplazym partnership is going at least 3x from here, and a lot more on the FDA approval. But thats why u are here...buying other people shares.

RE:BLA

U know what,i agree! And i agree with the odds u suggested.... these 2 owners are at helm since around 1 year and control 85% of all shares (!) , lets see what happens...

Steve33 wrote:
Its hard to be hopeful with the disastrous track record of this company. What I am feeling positive about is the BLA. They have spent two years on this with a new hired consultant for auditing. The product has no issues whatsoever. The company thrives with approval and is dead without it. But the odds are in our favour. 90% chance of approval in my mind or higher. The worst part is waiting for the submission. Surely it is soon as I believe Galbraith hinted as much two times during the meeting.

-----------------------
Facts are money is not a problem + riplazym partnership is
IMMINENT: LMNL just told you riplazym as been tested running in plant for 6 months, its a success. They met the FDA to submit and we're in may... plenty of time til end of june. Thats 2020 like they said in MDA! They can only say it that way. Same for partnership (next weeks), this is going to be a money printing machine... im sur we'll find a distributer with $$$;) By the way, the riplazym partnership will come with upfront money too.

6 months of cash, then SALP credit line if needed, THOMVEST owns lmnl, they finance companies like lmnl all the time if needed, money not a problem here...look at their website and all the businesses they manage, they know exactly what they are doing, owning 85% of all shares in lmnl. This quarter was not about money/revenue as u know at this point... but short term news. Thats why we are here;) And why the spammers spent all week-end onthis board.

"2020 remains an important and eventful year for the Company. While there are uncertainties for the year ahead, we remain focused on the resubmission of our Biologic License Application, or BLA to the Food and Drug Administration, or FDA for Ryplazim® (plasminogen), or Ryplazim® as a treatment of patients with congenital plasminogen deficiency, and the development of our small molecule pipeline . We also continue to plan and explore alternatives for the commercial launch of Ryplazim®, initially in the United States, if approved. We will continue to monitor and provide more updates as the situation unfolds."